ÂÜÀòÂÒÂ×

Catherine McMahan is currently the SVP of Non-Clinical Drug Development at Mozart Therapeutics, Inc., where they manage a range of drug development projects. With a distinguished background in biotechnology, they previously held positions such as Senior Director at Aptevo Therapeutics Inc., where they directed scientific staff and activities focused on autoimmune and oncology research. Catherine has a PhD in Immunobiology from Yale University and a Bachelor of Science in Microbiology and Immunology from the University of Washington. Their extensive experience encompasses managing multi-disciplined teams and leading organizations through transformative changes in research and development.